Regadenoson pharmacologic stress for myocardial perfusion imaging: A three-way comparison between regadenoson administered at peak exercise, during walk recovery, or no-exercise

Journal of Nuclear Cardiology

Volumn 20, Issue 2, 2013, Pages 214-221

  Thompson, Randall C ^a,b   Patil, Harshal ^b   Thompson, Elaine C ^a   Thomas, Gregory S ^c   Al Amoodi, Mohammed ^d   Kennedy, Kevin F ^b   Bybee, Kevin A ^a,b   Iain McGhie, A ^a,b   O'Keefe Jr , James H ^a,b   Oakes, Lisa ^a   Bateman, Timothy M ^a,b  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^d Stronger Hospital of Cook County   (United States)

Author keywords

A2A adenosine receptor agonists; Exercise; pharmacologic stress; stress testing

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; REGADENOSON;

ADULT; AGE; ARTICLE; ATRIOVENTRICULAR BLOCK; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG TOLERABILITY; DYSPNEA; EXERCISE; EXERCISE RECOVERY; EXERCISE TEST; FEMALE; FLUSHING; HEART FUNCTION TEST; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HEMODYNAMICS; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; NAUSEA; PEAK EXERCISE; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; REST; RETROSPECTIVE STUDY; SEX; SIDE EFFECT; SLOW DOWN WALK RECOVERY STATE; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; TREATMENT RESPONSE; VOMITING;

ADENOSINE A2 RECEPTOR AGONISTS; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PHYSICAL ENDURANCE; PREVALENCE; PURINES; PYRAZOLES; REPRODUCIBILITY OF RESULTS; REST; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS; WALKING;

EID: 84879506937     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-012-9660-4     Document Type: Article

References (15)

1. Henzlova MJ, Cerqueira MD, Hansen CL, Taillefer R, Yao SS. ASNC imaging guidelines for nuclear cardiology procedures; Stress protocols and tracers. J Nucl Cardiol 2009;16. doi: 10.1007/s12350-009-9062-4.
2. Pennell DJ, Mavrogeni SI, Forbat SM, Karwatowski SP, Underwood SR. Adenosine combined with dynamic exercise for myocardial perfusion imaging. J Am Coll Cardiol. 1995;25:1300-9.
3. Thomas GS, Prill NV, Majmundar H, Fabrizi RR, Thomas JJ, Hayashida C, et al. Treadmill exercise during adenosine infusion is safe, results in fewer adverse reactions, and improves myocardial perfusion image quality. J Nucl Cardiol 2000;7:439-46.
4. Ahlberg AW, Baghdasarian SB, Athar H, Thompsen JP, Katten DM, Noble GL, et al. Symptom-limited exercise combined with dipyridamole stress: Prognostic value in assessment of known or suspected coronary artery disease by use of gated SPECT imaging. J Nucl Cardiol 2008;15:42-56.
5. Thomas GS, Thompson RC, Miyamoto MI, Ip TK, Rice DL, Milikien D, et al. The RegEx trial: A randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging. J Nucl Cardiol 2009;16:63-72.
6. Holly TA, Satran A, Bromet DS, Mieres JH, Frey MJ, Elliott MD, et al. The impact of adjunctive adenosine infusion during exercise myocardial perfusion imaging: Results of the Both Exercise and Adenosine Stress Test (BEAST) trial. J Nucl Cardiol 2003;10:291-6.
7. Vitola JV, Brambatti JC, Caligaris F, Lesse CR, Nogueira PR, Joaquim AI, et al. Exercise supplementation to dipyridamole prevents hypotension, improves electrocardiogram sensitivity, and increases heart-to-liver activity ratio on Tc-99m sestamibi imaging. J Nucl Cardiol 2001;8:652-9.
8. Hendel RC, Bateman TM, Cerqueira MD, Iskandrian AE, Leppo JA, Blackburn B, et al. Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 2005;46:2069-75.
9. Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 2007;14:645-58.
10. Cerqueira MD, Nguyen P, Staehr P, Underwood SR, Iskandrian AE. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging 2008;1:307-16.
11. Kwon DH, Cerqueira MD, Young R, Houghtaling P, Lieber E, Menon V, et al. Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: Initial clinical experience in 1263 patients. J Nucl Cardiol 2010;17:853-7.
12. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.
13. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996;49:1373-9.
14. Rehm PK, Atkins FB, Ziessman HA, Green SE, Akin EA, Fox LM, et al. Frequency of extra-cardiac activity and its effect on 99Tcm-MIBI cardiac SPET interpretation. Nucl Med Commun 1996;17:851-6.
15. Partington SL, Lanka V, Hainer J, Blankstein R, Skali H, Foreman DE, et al. Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test. J Nucl Card 2012; doi: 10.1007/s12350-012-9562-5 (online first).